By Stathos, T.H., Lees, E.H., Stathos, J.G., Lipe, K.A. Ponsky, T., Rothenberg, S.S.Abstract
Gastroparesis is a chronic gastric motility disorder characterized by delayed gastric emptying of solid meals. Gastroparesis and associated symptoms are uncommon (4.6 per 10,000) with a 5:1 female to male ratio. In severe and chronic cases, patients may suffer dehydration, poor nutritional status, and poor glycémie control (in diabetics). The causes are numerous and include diabetic, post viral, post surgical, medication induced, neurologic, auto immune, and idiopathic. Idiopathic causes comprise up to half of all cases. Predominant symptoms are nausea, vomiting, early satiety, post prandial fullness/bloating, abdominal pain, and rarely weight loss. Typical treatments include pro- kinetic agents. Macrolide antibiotics, and metoclopromide are the mainstay of medical treatment, urecholine, domperidone and cisapride are less common alternatives. Gastric electrical stimulation (GES) entails the use of a set of pacing wires attached to the stomach and an electrical device that provides a low-frequency, high-energy stimulation to the stomach. In adults GES is an established treatment for gastroparesis, nausea, and vomiting refractory to standard medical treatment. The placement of the permanent gastric electric stimulator is it expensive and invasive. If the placement of a permanent stimulator is ineffective, removal re-quires a second operation. Our study was designed to determine if children with gastroparesis and related symptoms refractory to medical management would have beneficial effect from temporary GES as a test prior to placement of permanent GES.